As market stays cold, biotechs continue to cut programs, trials and staff
April showers bring few dollars. Following the shutdown of Silicon Valley Bank, which many biotechs relied on, tough market conditions continue to batter the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
